The Senate Committee on Health, Education, Labor, and Pensions has announced that Novo Nordisk CEO Lars Jorgensen will voluntarily testify about the high U.S. prices for weight loss drugs Ozempic and Wegovy. This decision cancels a scheduled vote to subpoena Novo's president Doug Langa. The hearing will discuss why these drugs are significantly more expensive in the U.S. compared to other countries.
(Reuters) -The Senate Committee on Health, Education, Labor, and Pensions said on Friday that Novo Nordisk CEO Lars Jorgensen has agreed to testify voluntarily in a hearing focusing on U.S.
PHOENIX — State Treasurer Kimberly Yee is asking Attorney General Kris Mayes to back away from any investigation of whether laws were broken in the awarding of a new foster
Prescription transfer bills cross finish line at General Assembly yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.